Effect of glucose-insulin-potassium (GIK) infusion on biomarkers of cardiovascular risk in ST elevation myocardial infarction (STEMI): insight into the failure of GIK.

Parikh, Shailja V; Abdullah, Shuaib M; Keeley, Ellen C; Cigarroa, Joaquin E; Addo, Tayo A; Warner, John J; Khera, Amit; de Lemos, James A; McGuire, Darren K

Parikh, Shailja V; Abdullah, Shuaib M; Keeley, Ellen C; Cigarroa, Joaquin E; Addo, Tayo A; Warner, John J; Khera, Amit; de Lemos, James A; McGuire, Darren K.

Affiliation

Parikh SV; Department of Internal Medicine, the University of Texas Southwestern Medical Center in Dallas, Texas 75235-9047, USA.

Diab Vasc Dis Res ; 4(3): 222-5, 2007 Sep.

Article in En | MEDLINE | ID: mdl-17907112

Subject(s)

Myocardial Infarction/drug therapy; Biomarkers/blood; C-Reactive Protein/analysis; Electrocardiography; Glucose/therapeutic use; Humans; Insulin/therapeutic use; Myocardial Infarction/blood; Myocardial Infarction/diagnosis; Natriuretic Peptide, Brain/blood; Peptide Fragments/blood; Potassium/therapeutic use; Time Factors; Treatment Failure

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Diab Vasc Dis Res Journal subject: ANGIOLOGIA / ENDOCRINOLOGIA Year: 2007 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links